Clinical Trials

Overview/Purpose

Vaccination for Hepatitis B in people with HIV does not always work. A new vaccine has been approved that may provide a better response.

The UCLA CARE Center is doing a study to look at whether this new vaccine will be more effective than the current standard Hepatitis B vaccine.

Basic eligibility criteria:

• Living with HIV and on HIV treatment for at least 8 weeks
• Previously received vaccines for hep B but they didn't work OR have never received hep B vaccine
• No history of hep B infection
• T-cell count > 100
• Viral load < 1,000

Principal Investigator:

For more information contact our outreach team at:

careoutreach@mednet.ucla.edu
310-557-9062
*There are limitations to the confidentiality of email communications. Do not include any sensitive health information if you choose to contact the study team via email.

Additional Resources: